Filippo Montemurro

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

Cancers

Nutrients

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Candiolo Cancer Institute Candiolo, FPO-IRCCS

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Candiolo Cancer Institute Candiolo, FPO-IRCCS Nov 05 2018

Italy

Direttore :: Day Hospital Oncologico Multidisciplinare

Publications

Luca Licata, Giulia Viale, Mario Giuliano, Curigliano Giuseppe, Mariana Chavez-MacGregor, Julia Foldi, Oluchi Oke, Joseph Collins, Lucia Del Mastro, Fabio Puglisi, Filippo Montemurro, Claudio Vernieri, Lorenzo Gerratana, Sara Giordano, Alessia Rognone, Lorenzo Sica, Oreste Davide Gentilini, Stefano Cascinu, Lajos Pusztai, Antonio Giordano, Carmen Criscitiello, Giampaolo Bianchini
Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer. NPJ breast cancer 9 (1) (2023)
Marianna Pellegrini, Fabio Dario Merlo, Elena Agnello, Taira Monge, Andrea Devecchi, Valentina Casalone, Filippo Montemurro, Ezio Ghigo, Anna Sapino, Simona Bo
Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy-A Narrative Review. Nutrients 15 (1) (2023)
Marianna Pellegrini, Fabio Dario Merlo, Elena Agnello, Taira Monge, Andrea Devecchi, Valentina Casalone, Filippo Montemurro, Ezio Ghigo, Anna Sapino, Simona Bo
Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy-A Narrative Review. Nutrients 15 (1) (2023)
Marina Elena Cazzaniga, Paolo Pronzato, Domenico Amoroso, Antonio Bernardo, Laura Biganzoli, Giancarlo Bisagni, Livio Blasi, Emilio Bria, Francesco Cognetti, Lucio Crinò, Michelino De Laurentiis, Lucia Del Mastro, Sabino De Placido, Alessandra Beano, Francesco Ferraù, Silva Foladore, Rosachiara Forcignanò, Teresa Gamucci, Ornella Garrone, Alessandra Gennari, Monica Giordano, Francesco Giotta, Filippo Giovanardi, Luciano Latini, Lorenzo Livi, Paolo Marchetti, Rodolfo Mattioli, Andrea Michelotti, Filippo Montemurro, Carlo Putzu, Ferdinando Riccardi, Giuseppina Ricciardi, Emanuela Romagnoli, Giuseppina Sarobba, Simon Spazzapan, Pierosandro Tagliaferri, Nicola Tinari, Giuseppe Tonini, Anna Turletti, Claudio Verusio, Alberto Zambelli, Giorgio Mustacchi
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. Cancers 16 (1) (2023)
Marianna Pellegrini, Fabio Dario Merlo, Elena Agnello, Taira Monge, Andrea Devecchi, Valentina Casalone, Filippo Montemurro, Ezio Ghigo, Anna Sapino, Simona Bo
Dysgeusia in Patients with Breast Cancer Treated with Chemotherapy-A Narrative Review. Nutrients 15 (1) (2023)
Benedetta Conte, Luca Boni, Giancarlo Bisagni, Antonio Durando, Giovanni Sanna, Stefania Gori, Ornella Garrone, Stefano Tamberi, Sabino De Placido, Francesco Schettini, Antonio Pazzola, Riccardo Ponzone, Filippo Montemurro, Gianluigi Lunardi, Rosario Notaro, Maria De Angioletti, Anna Turletti, Mauro Mansutti, Fabio Puglisi, Antonio Frassoldati, Mauro Porpiglia, Alessandra Fabi, Daniele Generali, Giovanni Scognamiglio, Maura Rossi, Fara Brasó-Maristany, Aleix Prat, Barbara Cardinali, Patrizia Piccioli, Martina Serra, Sonia Lastraioli, Claudia Bighin, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro
SNPs of aromatase predict long-term survival and aromatase inhibitor toxicity in patients with early breast cancer: a biomarker analysis of the GIM4 and GIM5 trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Marina Elena Cazzaniga, Paolo Pronzato, Domenico Amoroso, Antonio Bernardo, Laura Biganzoli, Giancarlo Bisagni, Livio Blasi, Emilio Bria, Francesco Cognetti, Lucio Crinò, Michelino De Laurentiis, Lucia Del Mastro, Sabino De Placido, Alessandra Beano, Francesco Ferraù, Silva Foladore, Rosachiara Forcignanò, Teresa Gamucci, Ornella Garrone, Alessandra Gennari, Monica Giordano, Francesco Giotta, Filippo Giovanardi, Luciano Latini, Lorenzo Livi, Paolo Marchetti, Rodolfo Mattioli, Andrea Michelotti, Filippo Montemurro, Carlo Putzu, Ferdinando Riccardi, Giuseppina Ricciardi, Emanuela Romagnoli, Giuseppina Sarobba, Simon Spazzapan, Pierosandro Tagliaferri, Nicola Tinari, Giuseppe Tonini, Anna Turletti, Claudio Verusio, Alberto Zambelli, Giorgio Mustacchi
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. Cancers 16 (1) (2023)
Eriseld Krasniqi, Francesca Sofia Di Lisa, Anna Di Benedetto, Maddalena Barba, Laura Pizzuti, Lorena Filomeno, Cristiana Ercolani, Nicola Tinari, Antonino Grassadonia, Daniele Santini, Mauro Minelli, Filippo Montemurro, Maria Agnese Fabbri, Marco Mazzotta, Teresa Gamucci, Giuliana D'Auria, Claudio Botti, Fabio Pelle, Flavia Cavicchi, Sonia Cappelli, Federico Cappuzzo, Giuseppe Sanguineti, Silverio Tomao, Andrea Botticelli, Marina Chiara Garassino, Marcello Maugeri-Saccà, Ruggero De Maria, Gennaro Ciliberto, Francesca Sperati, Patrizia Vici
The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer: The TRISKELE Multicenter Prospective Study. Cancers 14 (19) (2022)
Fabrice Andre, Thomas Filleron, Maud Kamal, Fernanda Mosele, Monica Arnedos, Florence Dalenc, Marie-Paule Sablin, Mario Campone, Hervé Bonnefoi, Claudia Lefeuvre-Plesse, William Jacot, Florence Coussy, Jean-Marc Ferrero, George Emile, Marie-Ange Mouret-Reynier, Jean-Christophe Thery, Nicolas Isambert, Alice Mege, Philippe Barthelemy, Benoit You, Nawale Hajjaji, Ludovic Lacroix, Etienne Rouleau, Alicia Tran-Dien, Sandrine Boyault, Valery Attignon, Pierre Gestraud, Nicolas Servant, Christophe Le Tourneau, Linda Larbi Cherif, Isabelle Soubeyran, Filippo Montemurro, Alain Morel, Amelie Lusque, Marta Jimenez, Alexandra Jacquet, Anthony Gonçalves, Thomas Bachelot, Ivan Bieche
Genomics to select treatment for patients with metastatic breast cancer. Nature 610 (7931) (2022)
Thibaut Sanglier, Alessandra Fabi, Carlos Flores, Evelyn M Flahavan, Claudia Pena-Murillo, Anne-Marie Meyer, Filippo Montemurro
T-DM1 after Pertuzumab plus Trastuzumab: Treatment Sequence-Induced Selection Bias in HER2-Positive Metastatic Breast Cancer. Cancers 14 (10) (2022)
Elisa Agostinetto, Filippo Montemurro, Fabio Puglisi, Carmen Criscitiello, Giampaolo Bianchini, Lucia Del Mastro, Martino Introna, Carlo Tondini, Armando Santoro, Alberto Zambelli
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives. Cancers 14 (9) (2022)
Enrico Berrino, Umberto Miglio, Sara Erika Bellomo, Carla Debernardi, Alberto Bragoni, Annalisa Petrelli, Eleonora Nacchiero, Silvia Giordano, Filippo Montemurro, Caterina Marchio, Tiziana Venesio, Anna Sapino
The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients. Cells 11 (12) (2022)
Mariarosaria Saponaro, Luigi Annunziata, Antonella Turla, Ilaria Viganò, Michelino De Laurentiis, Mario Giuliano, Lucia Del Mastro, Filippo Montemurro, Fabio Puglisi, Carmine De Angelis, Giuseppe Buono, Francesco Schettini, Grazia Arpino
Extended Adjuvant Endocrine Treatment in Luminal Breast Cancers in the Era of Genomic Tests. International journal of molecular sciences 23 (21) (2022)
Claudio Vernieri, Federico Nichetti, Luca Lalli, Luca Moscetti, Carlo Alberto Giorgi, Gaia Griguolo, Antonio Marra, Giovanni Randon, Carmen G Rea, Francesca Ligorio, Simone Scagnoli, Claudia De Angelis, Chiara Molinelli, Agnese Fabbri, Emanuela Ferraro, Dario Trapani, Andrea Milani, Elisa Agostinetto, Ottavia Bernocchi, Giovanna Catania, Amelia Vantaggiato, Michela Palleschi, Anna Moretti, Debora Basile, Marika Cinausero, Arta Ajazi, Lorenzo Castagnoli, Salvatore Lo Vullo, Lorenzo Gerratana, Fabio Puglisi, Nicla La Verde, Grazia Arpino, Andrea Rocca, Mariangela Ciccarese, Rebecca Pedersini, Alessandra Fabi, Daniele Generali, Agnese Losurdo, Filippo Montemurro, Curigliano Giuseppe, Lucia Del Mastro, Andrea Michelotti, Enrico Cortesi, Valentina Guarneri, Giancarlo Pruneri, Luigi Mariani, Filippo de Braud
Impact of Baseline and On-Treatment Glycemia on Everolimus-Exemestane Efficacy in Patients with Hormone Receptor-Positive Advanced Breast Cancer (EVERMET). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Federica Verginelli, Alberto Pisacane, Gennaro Gambardella, Antonio D'Ambrosio, Ermes Candiello, Marco Ferrio, Mara Panero, Laura Casorzo, Silvia Benvenuti, Eliano Cascardi, Rebecca Senetta, Elena Geuna, Andrea Balabio, Filippo Montemurro, Anna Sapino, Paolo M Comoglio, Carla Boccaccio
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition. Nature communications 12 (1) (2021)
Fabio Puglisi, Lorenzo Gerratana, Matteo Lambertini, Marcello Ceppi, Luca Boni, Filippo Montemurro, Stefania Russo, Claudia Bighin, Michelino De Laurentiis, Mario Giuliano, Giancarlo Bisagni, Antonio Durando, Anna Turletti, Ornella Garrone, Andrea Ardizzoni, Teresa Gamucci, Giuseppe Colantuoni, Adriano Gravina, Sabino De Placido, Francesco Cognetti, Lucia Del Mastro
Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer. NPJ breast cancer 7 (1) (2021)
Giovanna Chilà, Vincenzo Guarini, Danilo Galizia, Elena Geuna, Filippo Montemurro
The Clinical Efficacy and Safety of Neratinib in Combination with Capecitabine for the Treatment of Adult Patients with Advanced or Metastatic HER2-Positive Breast Cancer. Drug design, development and therapy 15 (2021)
Valentina Rossi, Berchialla Paola, Diana Giannarelli, Cecilia Nisticò, Gianluigi Ferretti, Simona Gasparro, Michelangelo Russillo, Giovanna Catania, Leonardo Vigna, Rossella Letizia Mancusi, Emilio Bria, Filippo Montemurro, Francesco Cognetti, Alessandra Fabi
Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2, MONALEESA 2, MONALEESA 7, MONARCH 3, FALCON, SWOG and FACT Trials. Cancers 11 (11) (2019)
Rossella Martinello, Paolo Becco, Patrizia Vici, Mario Airoldi, Lucia Del Mastro, Ornella Garrone, Carla Barone, Laura Pizzuti, Alessia D'Alonzo, Elisa Bellini, Andrea Milani, Alessandro Bonzano, Filippo Montemurro
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidity. The breast journal 25 (3) (2019)
Emiliano Cocco, F Javier Carmona, Pedram Razavi, Helen H Won, Yanyan Cai, Valentina Rossi, Carmen Chan, James Cownie, Joanne Soong, Eneda Toska, Sophie G Shifman, Ivana Sarotto, Peter Savas, Michael J Wick, Kyriakos P Papadopoulos, Alyssa Moriarty, Richard E Cutler, Francesca Avogadri-Connors, Alshad S Lalani, Richard P Bryce, Sarat Chandarlapaty, David M Hyman, David B Solit, Valentina Boni, Sherene Loi, Jose Baselga, Michael F Berger, Filippo Montemurro, Maurizio Scaltriti
Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2). Science signaling 11 (551) (2018)
Danilo Galizia, Andrea Milani, Elena Geuna, Rossella Martinello, Celeste Cagnazzo, Manuela Foresto, Virginia Longo, Paola Berchialla, Gianfranca Solinas, Adele Calori, Bruna Grasso, Chiara Volpone, Gisella Bertola, Gisella Parola, Giancarla Tealdi, Piero Luigi Giuliano, Anna Maria Ballari, Massimo Aglietta, Filippo Montemurro
Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study. Cancer medicine 7 (9) (2018)

Filippo Montemurro.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Filippo Montemurro